The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden

European Journal of Cardiovascular Prevention and Rehabilitation

Volumn 16, Issue 5, 2009, Pages 576-582

  Ringborg, Anna ^a   Yin, Donald D ^c   Martinell, Mats ^b   Stålhammar, Jan ^b   Lindgren, Peter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cardiovascular disease; Costs; Economic; Register data; Type 2 diabetes

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

ACUTE HEART INFARCTION; AGED; AMPUTATION; ARTICLE; COHORT ANALYSIS; FEMALE; GROUPS BY AGE; HEALTH CARE COST; HEART FAILURE; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PATIENT CARE; POPULATION RESEARCH; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; STROKE; SWEDEN;

EID: 72449146824     PISSN: 17418267     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJR.0b013e32832d193b     Document Type: Article

References (28)

1. Ettaro L, Songer TJ, Zhang P, Engelgau MM. Cost-of-illness studies in diabetes mellitus. Pharmacoeconomics 2004; 22:149-164.
2. Brandle M, Zhou H, Smith BR, Marriott D, Burke R, Tabaei BP, et al. The direct medical cost of type 2 diabetes. Diabetes Care 2003; 26:2300-2304.
3. O'Brien JA, Patrick AR, Caro J. Estimates of direct medical costs for microvascular and macrovascular complications resulting from type 2 diabetes mellitus in the United States in 2000. Clin Ther 2003; 25:1017-1038.
4. Jonsson B. Revealing the cost of type II diabetes in Europe. Diabetologia 2002; 45:S5-S12.
5. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008; 31:596-615.
6. Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of type II diabetes. Diabetologia 2002; 45:S13-S17.
7. Brown JB, Pedula KL, Bakst AW. The progressive cost of complications in type 2 diabetes mellitus. Arch Intern Med 1999; 159:1873-1880.
8. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339:229-234.
9. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA 1979; 241:2035-2038.
10. Nichols GA, Brown JB. The impact of cardiovascular disease on medical care costs in subjects with and without type 2 diabetes. Diabetes Care 2002; 25:482-486.
11. Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease. J Manag Care Pharm 2006; 12:546-554.
12. Clarke P, Gray A, Legood R, Briggs A, Holman R. The impact of diabetesrelated complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65). Diabet Med 2003; 20:442-450.
13. Gilmer TP, O'Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, et al. Predictors of health care costs in adults with diabetes. Diabetes Care 2005; 28:59-64.
14. Ringborg A, Lindgren P, Martinell M, Yin DD, Schon S, Stalhammar J. Prevalence and incidence of type 2 diabetes and its complications 1996-2003-estimates from a Swedish population-based study. Diabet Med 2008; 25:1178-1186.
15. Ringborg A, Martinell M, Stalhammar J, Yin DD, Lindgren P. Resource use and costs of type 2 diabetes in Sweden-estimates from population-based register data. Int J Clin Pract 2008; 62:708-716.
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15:539-553.
17. Swedish Association of Diabetology. Diagnostic criteria for diabetes 1998. Available from http://www.diabetolognytt.se/nummer3-97/ diagnoskriterier.html. [Accessed 26 October 2006]
18. Jönsson L, Gruner U. What is the cost of health care of the elderly? Cost calculations for outpatient, inpatient, institutional and informal care. Stockholm: Stockholm Aging Research Center; 2001.
19. Uppsala Akademiska Hospital. Price list of health care 2007. Available from http://www.externt9.lul.se/svn/uppsala07.xls. [Accessed 10 May 2008]
20. The Swedish Pharmaceutical Benefits Board. Pharmaceutical price list. Available from http://www.lfn.se. [Accessed 14 April 2008]
21. Eliasson B, Cederholm J, Nilsson P, Gudbjornsdottir S. The gap between guidelines and reality: type 2 diabetes in a National Diabetes Register 1996-2003. Diabet Med 2005; 22:1420-1426.
22. Zethraeus N, Molin T, Henriksson P, Jonsson B. Costs of coronary heart disease and stroke: the case of Sweden. J Intern Med 1999; 246:151-159.
23. Statistics Sweden. Prices and consumption. Available from http:// www.scb.se. [Accessed 15 August 2008]
24. Vittinghoff E, Glidden DV, Shiboski SC, McCulloch CE. Regression methods in biostatistics. New York: Springer Science+Business Media Inc.; 2005.
25. Tiemann O. Variations in hospitalisation costs for acute myocardial infarction-a comparison across Europe. Health Econ 2008; 17:S33-S45.
26. Epstein D, Mason A, Manca A. The hospital costs of care for stroke in nine European countries. Health Econ 2008; 17:S21-S31.
27. Rayce SL, Christensen U, Hougaard CO, Diderichsen F. Economic consequences of incident disease: the effect on loss of annual income. Scand J Public Health 2008; 36:258-264.
28. Hamalainen H, Maki J, Virta L, Keskimaki I, Mahonen M, Moltchanov V, et al. Return to work after first myocardial infarction in 1991-1996 in Finland. Eur J Public Health 2004; 14:350-353.